Stryker Gains as Recovery Optimism Builds Ahead of Q2 Results

Stryker Corporation (SYK) is up 3.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to improving sentiment around Stryker’s recovery from its spring cyber disruption, along with growing optimism ahead of its second-quarter results scheduled for July 30, 2026. This could also reflect investors responding to a recent price-target increase that highlighted expectations for stronger growth in the second half of 2026.

Details:

Stryker is scheduled to report second-quarter 2026 financial results on July 30, 2026, which may have supported buying interest ahead of earnings.

In first-quarter results released on April 30, 2026, the company maintained full-year 2026 guidance for organic sales growth of 8.0% to 9.5% and adjusted earnings per share of $14.90 to $15.10.

Stryker’s first-quarter filings also flagged a cybersecurity incident first disclosed in March 2026, and recent market commentary pointed to expectations that the company can recover from that disruption.

The company also completed its acquisition of Amplitude Vascular Systems in May 2026, adding another growth driver to its peripheral vascular portfolio.

Sources:

Stryker, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$SYK Insider Trading Activity

$SYK insiders have traded $SYK stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.

Here’s a breakdown of recent trading of $SYK stock by insiders over the last 6 months:

RONDA E STRYKER has made 0 purchases and 24 sales selling 810,000 shares for an estimated $278,511,937.
ROBERT S FLETCHER (VP, Chief Legal Officer) has made 0 purchases and 6 sales selling 4,544 shares for an estimated $1,394,409.
JAMES ANDREW PIERCE (Group President) sold 475 shares for an estimated $175,214

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive SYK Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$SYK Hedge Fund Activity

We have seen 1,024 institutional investors add shares of $SYK stock to their portfolio, and 968 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FISHER ASSET MANAGEMENT, LLC removed 2,658,808 shares (-85.3%) from their portfolio in Q1 2026, for an estimated $862,410,962
WELLINGTON MANAGEMENT GROUP LLP added 1,628,431 shares (+25.1%) to their portfolio in Q1 2026, for an estimated $528,197,879
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,100,673 shares (+241.9%) to their portfolio in Q1 2026, for an estimated $357,014,294
SG AMERICAS SECURITIES, LLC added 958,715 shares (+169.2%) to their portfolio in Q1 2026, for an estimated $310,968,797
WINSLOW CAPITAL MANAGEMENT, LLC removed 859,330 shares (-66.1%) from their portfolio in Q1 2026, for an estimated $278,732,278
BLUESPRUCE INVESTMENTS, LP removed 745,250 shares (-79.0%) from their portfolio in Q1 2026, for an estimated $241,729,290
GREENLEAF TRUST removed 709,525 shares (-4.5%) from their portfolio in Q2 2026, for an estimated $223,386,850

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$SYK Government Contracts

We have seen $65,471,379 of award payments to $SYK over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

MAKO 4 ROBOTIC SYSTEM: $3,643,551
4569335966!MAKO4-TKA-PKA-THA50: $920,000

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$SYK Congressional Stock Trading

Members of Congress have traded $SYK stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $SYK stock by members of Congress over the last 6 months:

REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 06/02, 01/23.
SENATOR ALAN ARMSTRONG sold up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$SYK Analyst Ratings

Wall Street analysts have issued reports on $SYK in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 05/01/2026
BTIG issued a "Buy" rating on 05/01/2026

To track analyst ratings and price targets for $SYK, check out Quiver Quantitative's $SYK forecast page.

$SYK Price Targets

Multiple analysts have issued price targets for $SYK recently. We have seen 13 analysts offer price targets for $SYK in the last 6 months, with a median target of $385.0.

Here are some recent targets:

An analyst from BMO Capital set a target price of $369.0 on 07/09/2026
Vijay Kumar from Evercore ISI Group set a target price of $350.0 on 07/06/2026
Mike Kratky from Leerink Partners set a target price of $407.0 on 06/05/2026
Matt Miksic from Barclays set a target price of $394.0 on 05/04/2026
Richard Newitter from Truist Securities set a target price of $330.0 on 05/04/2026
Larry Biegelsen from Wells Fargo set a target price of $418.0 on 05/01/2026
Robbie Marcus from JP Morgan set a target price of $400.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.